- Using AI to systematically evaluate the effect of different eligibility criteria on cancer trial populations and outcomes with real-world data
- Ultimately identifying a wider and more accurate pool of patients that could potentially benefit from treatments
- Facilitating the design of more inclusive trials while maintaining safeguards for patient safety
Speaker(s):
Vishwa Kolla
Associate Director, Advanced Analytics
Takeda